Structure

InChI Key MKXZASYAUGDDCJ-NJAFHUGGSA-N
Smiles COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3
InChI
InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H25NO
Molecular Weight 271.4
AlogP 3.38
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 1.0
Polar Surface Area 12.47
Molecular species BASE
Aromatic Rings 1.0
Heavy Atoms 20.0
Assay Description Organism Bioactivity Reference
Binding affinity was measured against N-methyl-D-aspartate (NMDA) receptor in rat using [3H]CGS-19,755 as radioligand at 10 uM None 2.0 %
Percent inhibition of veratridine-induced glutamate release in rat brain slices at 10000 nmol/L Rattus norvegicus 5.0 %
Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1 Cavia porcellus 348.0 nM
Displacement of [3H]pentazocine from sigma1 receptor in guinea pig membrane Cavia porcellus 232.0 nM
Displacement of [3H]pentazocine from sigma1 receptor in guinea pig membrane in presence of phenytoin Cavia porcellus 15.2 nM
DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) None 2.71 nM DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) None 1.44 nM
Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting Homo sapiens 36.3 %
Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens -21.9 %
Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 15.9 %
Drug uptake in lysosomes of human Fa2N-4 cells assessed as inhibition of LysoTracker Red fluorescence at 500 uM after 30 mins relative to control Homo sapiens 25.0 %
Inhibition of human CYP2D6 at 10 uM Homo sapiens 94.37 %
Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in guinea pig brain membranes incubated for 1 hr by liquid scintillation counting method Cavia porcellus 63.0 nM
Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in guinea pig brain membranes incubated for 1 hr in presence of 250 uM phenytoin liquid scintillation counting method Cavia porcellus 10.0 nM

Environmental Exposure

Countries
USA

Cross References

Resources Reference
ChEBI 4470
ChEMBL CHEMBL52440
DrugBank DB00514
DrugCentral 842
FDA SRS 7355X3ROTS
Guide to Pharmacology 6953
PharmGKB PA449273
SureChEMBL SCHEMBL29949
ZINC ZINC000003201907